Nathan Citri
- Topics
- Enzyme function and inhibition (17 papers)Antibiotic Resistance in Bacteria (12 papers)Antibiotics Pharmacokinetics and Efficacy (11 papers)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Nathan Citri
49 papers receiving 864 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 680
- Molecular Medicine 272
- Pharmacology 228
- Materials Chemistry 126
- Organic Chemistry 109
Countries citing papers authored by Nathan Citri
This map shows the geographic impact of Nathan Citri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Citri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Citri more than expected).
Fields of papers citing papers by Nathan Citri
This network shows the impact of papers produced by Nathan Citri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Citri. The network helps show where Nathan Citri may publish in the future.
Co-authorship network of co-authors of Nathan Citri
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Citri. A scholar is included among the top collaborators of Nathan Citri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Citri. Nathan Citri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 34 | |
| 3 | 13 | |
| 4 | 17 | |
| 5 | 75 | |
| 6 | 28 | |
| 7 | 27 | |
| 8 | 20 | |
| 9 | 12 | |
| 10 | 59 | |
| 11 | 33 | |
| 12 | 16 | |
| 13 | THE ROLE OF PENICILLINASE IN STAPHYLOCOCCAL INFECTIONS. | 4 |
| 14 | 15 | |
| 15 | 35 | |
| 16 | 70 | |
| 17 | 3 | |
| 18 | 20 | |
| 19 | 51 | |
| 20 | 29 |
About Nathan Citri
Nathan Citri is a scholar working on Molecular Medicine, Pharmacology and Business and International Management, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Enzyme function and inhibition (17 papers), Antibiotic Resistance in Bacteria (12 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). The work is most often cited by research in Molecular Medicine (272 citations), Pharmacology (228 citations) and Molecular Biology (680 citations). Nathan Citri has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Naomi Zyk, N. Garber, M. R. Pollock, A. Samuni, Michael Sela, N. Grossowicz, H.S. Moyed, Shlomo Rottem, Yolanta Fishman and Amram Samuni. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.